Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Patients & consumers

Giving babies a healthier start

Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?

Patients & consumers

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.